PT - JOURNAL ARTICLE AU - Wei Wang AU - Tana S Pottorf AU - Henry H Wang AU - Ruochen Dong AU - Matthew A. Kavanaugh AU - Joseph T. Cornelius AU - Udayan Apte AU - Michele T Pritchard AU - Madhulika Sharma AU - Pamela V Tran TI - IFT-A deficiency in juvenile mice impairs biliary development and exacerbates ADPKD liver disease AID - 10.1101/2020.09.10.289645 DP - 2020 Jan 01 TA - bioRxiv PG - 2020.09.10.289645 4099 - http://biorxiv.org/content/early/2020/09/10/2020.09.10.289645.short 4100 - http://biorxiv.org/content/early/2020/09/10/2020.09.10.289645.full AB - Polycystic liver disease (PLD) is characterized by the growth of numerous biliary cysts and presents in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD), causing significant morbidity. Interestingly, deletion of intraflagellar transport-B (IFT-B) genes in adult mouse models of ADPKD attenuates severity of PKD and PLD. Here we examine the role of deletion of IFT-A gene, Thm1, in PLD of juvenile and adult Pkd2 conditional knock-out mice. Perinatal deletion of Thm1 results in disorganized and expanded biliary regions, biliary fibrosis, shortened primary cilia on CK19+ biliary epithelial cells, and reduced Notch signaling. In contrast, perinatal deletion of Pkd2 causes PLD, with multiple CK19+ biliary epithelial cell-lined cysts, fibrosis, lengthened primary cilia, and increased Notch and ERK signaling. Perinatal deletion of Thm1 in Pkd2 conditional knock-out mice increased hepatomegaly and liver necrosis, indicating enhanced liver disease severity. In contrast to effects in the developing liver, deletion of Thm1 in adult mice, alone and together with Pkd2, did not cause a biliary phenotype nor affect Pkd2-mutant PLD, respectively. However, similar to juvenile PLD, Notch and ERK signaling were increased in adult Pkd2-mutant cyst-lining cholangiocytes. Taken together, Thm1 is required for biliary tract development, likely by enabling Notch signaling, and proper biliary development restricts PLD severity. Unlike IFT-B genes, Thm1 does not affect hepatic cystogenesis, suggesting divergent regulation of signaling and cystogenic processes in the liver by IFT-B and –A. Notably, increased Notch signaling in cyst-lining cholangiocytes may indicate that aberrant activation of this pathway promotes hepatic cystogenesis, presenting as a novel potential therapeutic target.Competing Interest StatementThe authors have declared no competing interest.